ECSP961944A - PHARMACEUTICAL FORMULATIONS - Google Patents
PHARMACEUTICAL FORMULATIONSInfo
- Publication number
- ECSP961944A ECSP961944A ECSP961944A ECSP961944A EC SP961944 A ECSP961944 A EC SP961944A EC SP961944 A ECSP961944 A EC SP961944A EC SP961944 A ECSP961944 A EC SP961944A
- Authority
- EC
- Ecuador
- Prior art keywords
- pharmaceutical formulations
- drug
- optionally
- molecular weight
- ethylene oxide
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- 238000010874 in vitro model Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
La invención proporciona una formulación farmacéutica de liberación controlada para la administración oral, compuesta esencialmente por un fármaco activo; poli(óxido de etileno) de bajo peso molecular, hidroxipropilmetil celulosa; excipientes de comprimidos; y opcionalmente uno o más polímeros entéricos. Las formulaciones conforme a la invención producen una velocidad constante de liberación del fármaco en modelos in vitro del tracto gastrointestinal.The invention provides a controlled release pharmaceutical formulation for oral administration, consisting essentially of an active drug; low molecular weight poly (ethylene oxide), hydroxypropylmethyl cellulose; tablet excipients; and optionally one or more enteric polymers. The formulations according to the invention produce a constant rate of drug release in in vitro models of the gastrointestinal tract.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961944 ECSP961944A (en) | 1996-11-21 | 1996-11-21 | PHARMACEUTICAL FORMULATIONS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961944 ECSP961944A (en) | 1996-11-21 | 1996-11-21 | PHARMACEUTICAL FORMULATIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP961944A true ECSP961944A (en) | 1997-10-17 |
Family
ID=42042670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP961944 ECSP961944A (en) | 1996-11-21 | 1996-11-21 | PHARMACEUTICAL FORMULATIONS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP961944A (en) |
-
1996
- 1996-11-21 EC ECSP961944 patent/ECSP961944A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR004335A1 (en) | PHARMACEUTICAL FORMULATIONS | |
| HUT77886A (en) | Freeze-dried preparations containing ondansetron | |
| AR039744A1 (en) | METHODS AND DOSAGE FORMS TO INCREASE THE SOLUBILITY OF PHARMACOS COMPOSITIONS FOR CONTROLLED ADMINISTRATION | |
| EP1120109A3 (en) | Rapidly disintegrating and fast dissolving solid dosage form | |
| HUP9904174A2 (en) | Pharmaceutical composition for transdermic delivery | |
| DK1256343T3 (en) | Flibanserin for the treatment of extrapyramidal movement disorders | |
| AR022589A1 (en) | A CAPSULE THAT INCLUDES A SPONTANELY DISPERSABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, A SPONTANELY DISPERSABLE PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION AND THE USE FOR THE PREPARATION OF A TREATMENT MEDICATION | |
| ATE235895T1 (en) | DRUG DELIVERY SYSTEM CONTAINING A HARD-PACKED, SOLID DRUG BASE | |
| ES2195342T3 (en) | PHARMACEUTICAL FORMULATION OF OMEPRAZOL. | |
| AR040722A1 (en) | FORMULATIONS AND DOSAGE FORMS FOR THE CONTROLLED ADMINISTRATION OF TOPIRAMATO | |
| CO5170471A1 (en) | MODIFIED RELEASE TABLETS INCLUDING AMOXYLIN AND POTASSIUM CLAVULANATE | |
| EP0966966A3 (en) | Nefazodone dosage form | |
| MA25323A1 (en) | GALENIC FORMS WITH RAPID DELIVERY IN THE MOUTH AND PREPARATION METHOD THEREOF. | |
| ATE298324T1 (en) | DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
| WO2007079082A3 (en) | Gastric release pulse system for drug delivery | |
| AR011919A1 (en) | FORMULATION IN TABLETS OR SWALLOWING CAPSULES OF PARACETAMOL (N-ACETIL-P-AMINOFENOL) AND PROCEDURE TO PREPARE IT | |
| HUP0105481A2 (en) | Pharmaceutical compositions containing clarithromycin and process for their preparation and their use | |
| DK1608349T3 (en) | Oral delivery system comprising an antibacterial and an anti-inflammatory agent | |
| RU2003105812A (en) | COMPOSITIONS AND DOSED FORMS INTENDED FOR USE IN THE ORAL CAVITY FOR THE TREATMENT OF MYCOSIS | |
| ES2194618T1 (en) | ORALALLY DISINTEGRABLE COMPOSITION THAT MIRTAZAPINE INCLUDES. | |
| ECSP961944A (en) | PHARMACEUTICAL FORMULATIONS | |
| MXPA02011533A (en) | NOVEL FORMULATIONS OF agr; 2, 4 DISULFOPHENYL N TERT BUTYLNITRONE. | |
| GT199600094A (en) | ORAL PHARMACEUTICAL FORMULATIONS OF PROLONGED LIBERATION | |
| EA200600679A1 (en) | PHARMACEUTICAL COMPOSITION OF CONTROLLED GRIPPING AND METHOD OF ITS PREPARATION | |
| CN108601827A (en) | Immune induction composition for promoting and pharmaceutical vaccine compositions |